Well I'm going against the current line of thought.
My bet is on Pre Clinical results, ie the work that has been done on Alzheimer's and possibly other neurological stuff show exciting possibilities for the use of MonePantel in that space. Which would confirm Dr Thurns vision of seeing PAA as Global leaders in the neoro area in the not to distant future which he states toward the end of this presentation
Hopefully resulting in a SP kick then a CR.
Good luck to all
Ann: Trading Halt, page-24
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $62.98K | 324.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 108063 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 197665 | 4 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |